Inventor · disambiguated record
De-Chao Yu
Also filed as: YU DE C · YU DE CHAO · YU DE-CHAO MICHAEL
23 granted patents·11 pending applications·721 citations·filing 1997–2017
97Inventor score
Files withCELL GENESYS INC23CALYDON INC3COLD GENESYS INC2INNOVENT BIOLOGICS SUZHOU CO LTD2HENDERSON DANIEL R1
Top patents by PatentIndex Score
34 records- 0196US7968333B2Adenovirus vectors containing cell status-specific response elements and methods of use thereofCOLD GENESYS INC·Filed 2007·Granted Jun 28, 2011·62 cites·5 claims
- 0296US6692736B2Cell-specific adenovirus vectors comprising an internal ribosome entry siteCELL GENESYS INC·Filed 2001·Granted Feb 17, 2004·129 cites·41 claims
- 0396US6436394B1Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereofCELL GENESYS INC·Filed 2000·Granted Aug 20, 2002·90 cites·26 claims
- 0493US7048920B2Recombinant oncolytic adenovirus for human melanomaCELL GENESYS INC·Filed 2002·Granted May 23, 2006·54 cites·19 claims
- 0592US6916918B2Human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereofCELL GENESYS INC·Filed 2001·Granted Jul 12, 2005·32 cites·14 claims
- 0692US6911200B2Methods of treating neoplasia with combination of target-cell specific adenovirus, chemotherapy and radiationCELL GENESYS INC·Filed 2001·Granted Jun 28, 2005·30 cites·9 claims
- 0789USRE42373EAdenovirus vectors containing cell status-specific response elements and methods of use thereofCOLD GENESYS INC·Filed 2008·Granted May 17, 2011·4 cites·31 claims
- 0889US7575919B2Adenovirus vectors containing cell status-specific response elements and methods of use thereofCELL GENESYS INC·Filed 2004·Granted Aug 18, 2009·11 cites·9 claims
- 0989US6991935B2Target cell-specific adenoviral vectors containing E3 and methods of use thereofCELL GENESYS INC·Filed 2002·Granted Jan 31, 2006·16 cites·19 claims
- 1088US7364727B2Metastatic colon cancer specific promoter and uses thereofCELL GENESYS INC·Filed 2003·Granted Apr 29, 2008·19 cites·12 claims
- 1188US6197293B1Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereofCALYDON INC·Filed 1998·Granted Mar 6, 2001·54 cites·54 claims
- 1287US7074618B2Adenoviral E1A/E1B complementing cell lineCELL GENESYS INC·Filed 2004·Granted Jul 11, 2006·14 cites·10 claims
- 1387US6852528B2Human and mouse uroplakin II gene transcriptional regulatory elementsCELL GENESYS INC·Filed 2001·Granted Feb 8, 2005·26 cites·27 claims
- 1484US7276233B2Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapyCELL GENESYS INC·Filed 2005·Granted Oct 2, 2007·2 cites·4 claims
- 1584US6495130B1Target cell-specific adenoviral vectors containing E3 and methods of use thereofCALYDON INC·Filed 1999·Granted Dec 17, 2002·54 cites·15 claims
- 1683US6432700B1Adenovirus vectors containing heterologous transcription regulatory elements and methods of using sameCELL GENESYS INC·Filed 1998·Granted Aug 13, 2002·65 cites·17 claims
- 1780US7319033B2Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereofCELL GENESYS INC·Filed 2002·Granted Jan 15, 2008·9 cites·19 claims
- 1880US6900049B2Adenovirus vectors containing cell status-specific response elements and methods of use thereofCELL GENESYS INC·Filed 1999·Granted May 31, 2005·26 cites·31 claims
- 1975US7371570B2Cell-specific adenovirus vector comprising EBV-specific promoterCELL GENESYS INC·Filed 2003·Granted May 13, 2008·4 cites·16 claims
- 2072US10913801B2PD-1 antibodiesINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2017·Granted Feb 9, 2021·1 cites·16 claims
- 2168US2008076173A1Adenovirus vectors containing cell status-specific response elements and methods of use thereofCELL GENESYS INC·Filed 2007·Application pending·0 cites
- 2268US2008171390A1Adenovirus vectors containing cell status-specific response elements and methods of use thereofCELL GENESYS INC·Filed 2007·Application pending·0 cites
- 2368US2008166797A1Adenovirus vectors containing cell status-specific response elements and methods of use thereofCELL GENESYS INC·Filed 2007·Application pending·0 cites
- 2467US2006188479A1Adenovirus vectors containing cell status-specific response elements and methods of use thereofYU DE C·Filed 2005·Application pending·0 cites
- 2563US2009297483A1Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereofCELL GENESYS INC·Filed 2007·Application pending·0 cites
- 2662US2008247996A1Methods of treating neoplasia with combination target cell-specific adenovirus, chemotherapy and radiationCELL GENESYS INC·Filed 2007·Application pending·0 cites
- 2758US2005136035A1Cell specific replication-competent viral vectors comprising a self processing peptide cleavage siteFiled 2004·Application pending·0 cites
- 2857US2009156796A1Metastatic colon cancer specific promoter and uses thereofCELL GENESYS INC·Filed 2008·Application pending·0 cites
- 2956US6406861B1Methods of enhancing effectiveness of therapeutic viral immunogenic agent administrationCELL GENESYS INC·Filed 1999·Granted Jun 18, 2002·12 cites·26 claims
- 3056US2004146489A1Cell-specific adenovirus vectors comprising an internal ribosome entry siteFiled 2003·Application pending·0 cites
- 3155US2009270485A1Cell specific replication-competent viral vectors comprising a self processing peptide cleavage siteCELL GENESYS INC·Filed 2008·Application pending·0 cites
- 3245US2006024273A1Target cell-specific adenoviral vectors containing E3 and methods of use thereofHENDERSON DANIEL R·Filed 2005·Application pending·0 cites
- 3344US6051417AProstate cancer drug screening using hKLK2 enhancerCALYDON INC·Filed 1997·Granted Apr 18, 2000·7 cites·11 claims
- 3442US10597454B2PD-1 antibodiesINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2016·Granted Mar 24, 2020·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when De-Chao Yu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →